NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) | PAR 20 049

FAQs: NINDS Postdoctoral Mentored Career Development Award (K01) - PAR-20-049 (No Independent Clinical Trial Allowed)

What is this funding opportunity?

This opportunity is the NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed), Funding Opportunity Number PAR-20-049. It is an NIH career development grant administered by the National Institutes of Health and aligned with the National Institute of Neurological Disorders and Stroke (NINDS). The program is designed to help exceptional postdoctoral researchers in neuroscience and neurological disorders research transition into independent investigators.

What is the main goal of the K01 program described here?

The central goal is to provide protected, mentored time and structured support so a postdoctoral researcher can build a strong foundation for independence. The FOA frames the K01 as a launchpad toward an independent research career, with the expectation that by the end of the K01 period the awardee will have a mature research direction, the skills and track record needed to compete for independent funding, and professional readiness to become a leader in the field.

What are the two required elements applicants must combine?

The program requires two core elements to be integrated into a coherent plan: (1) a potentially high-impact research project, and (2) a detailed, deliberate career development plan. The intent is that the research and training plans are tightly connected and jointly move the candidate toward independence.

Who is this K01 intended for in terms of career stage?

This K01 is designed for candidates in the earlier-to-middle portion of postdoctoral training. NINDS encourages applications between the second and fourth year of cumulative mentored postdoctoral research experience, and candidates may be supported under this mechanism as long as they are within the first six years of cumulative postdoctoral experience.

Why does NINDS encourage applying relatively early in postdoctoral training?

The FOA emphasizes that NINDS places heavy weight on the career development plan as a core component of the application, not as an afterthought. Applying earlier is meant to ensure the applicant can meaningfully benefit from a structured training strategy and sustained mentorship while building toward independence.

What kinds of activities can be included in the career development plan?

The FOA expects a thoughtful training strategy that is integrated with the research plan and clearly supports independence. Examples mentioned include new technical skill acquisition, formal coursework where appropriate, grant writing training, presentations, networking, and other professional development activities.

What does "No Independent Clinical Trial Allowed" mean for this K01?

Applicants may not propose to lead an independent clinical trial, a clinical trial feasibility study, or an ancillary study to an existing clinical trial as the main research plan under this K01. In other words, the candidate cannot be positioned as the independent trial lead within the proposed K01 research.

Can a K01 candidate get clinical trial experience under this FOA?

Yes. The FOA allows the candidate to gain clinical trial experience if the clinical trial is led by a mentor or co-mentor. This means the candidate may participate in clinical trial-related activities for training purposes, but the proposed K01 research plan must not be structured around the candidate serving as the independent clinical trial lead.

What should applicants keep in mind when planning research that touches clinical trials?

The key planning distinction is leadership versus training involvement. The FOA permits clinical trial experience under mentor leadership, but it prohibits the K01 research plan from being centered on the candidate leading an independent clinical trial, feasibility study, or ancillary study. Applicants should ensure the proposed work stays within that boundary.

What types of organizations are eligible to apply?

Organizational eligibility is broad and includes many common U.S.-based applicant organizations, such as public and private institutions of higher education; nonprofits (with or without 501(c)(3) status); for-profit organizations (including small businesses and other than small businesses); and various levels of government (state, county, city/township, and special district). The FOA also lists independent school districts and public housing authorities/Indian housing authorities as eligible.

Are certain institution types specifically highlighted as eligible or encouraged?

Yes. The FOA highlights additional eligible applicant types NIH often encourages to participate, including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); eligible federal agencies; faith-based or community-based organizations; regional organizations; U.S. territories or possessions; and tribal governments or tribal organizations (including distinctions between federally recognized and other-than-federally recognized entities).

Can a foreign (non-U.S.) organization apply as the main applicant?

No. The FOA states that non-domestic (non-U.S.) entities (foreign organizations/institutions) are not eligible to apply as the applicant organization.

Are non-U.S. components of U.S. organizations eligible?

No. The FOA specifies that non-domestic components of U.S. organizations are not eligible.

Are any foreign activities allowed at all under this FOA?

Yes, in a limited way. The FOA notes that foreign components (as defined in the NIH Grants Policy Statement) are allowed. This generally means certain scientifically justified activities can occur abroad under an otherwise eligible U.S. applicant organization, subject to NIH rules.

What is the funding instrument and activity area for this opportunity?

The opportunity is an NIH discretionary grant (Funding Instrument: Grant) in the health area (Funding Activity Category: Health). It is administered by the National Institutes of Health and aligned with NINDS.

What is the CFDA number listed for this opportunity?

The opportunity record lists CFDA number 93.853.

What are the dates shown in the opportunity record?

The record lists an original closing date of 2023-05-07 and a creation date of 2019-11-07.

Should applicants rely on the dates in older listings?

The provided description advises applicants to verify current receipt dates and active status in the official NIH/Grants.gov listing, because NIH FOAs can be reissued, updated, or closed over time even when older records circulate.

How should an applicant position their application to match the intent of this K01?

Based on the FOA description, a strong fit is a mentored transition plan for a postdoc who is far enough along to propose a compelling research direction, but early enough to benefit substantially from a structured development plan and sustained mentorship. The mentorship team, training environment, career development activities, and research plan should fit together as a coherent pathway toward independence, while respecting the boundary that the candidate will not lead an independent clinical trial as part of the proposed work.